Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
6%
Aldosterone
20%
Amiodarone
50%
Angiotensin
20%
Antiarrhythmic Agent
40%
Antiarrhythmic Drug
40%
Anticoagulant Agent
40%
Anticoagulation Therapy
8%
Antiinflammatory Agent
6%
Antithrombotic Therapy
6%
Antivitamin K
5%
Atrial Fibrillation
100%
Beta Adrenergic Receptor Blocking Agent
26%
Brain Infarction
13%
Cardiovascular Risk
6%
Cerebrovascular Accident
6%
Combination Therapy
9%
Comorbidity
9%
Congestive Heart Failure
19%
Coronary Artery Disease
13%
Dabigatran
20%
Diabetes Mellitus
6%
Direct Oral Anticoagulant
29%
Drug Choice
6%
Drug Concentration
6%
Drug Interaction
8%
Drug-Drug Interaction
33%
Dyslipidemia
6%
Etacizine
26%
Heart Arrhythmia
46%
Heart Death
6%
Heart Infarction
6%
Mineralocorticoid Antagonist
11%
Monotherapy
6%
Omega-3 Fatty Acid
14%
Persistent Atrial Fibrillation
20%
Pharmacodynamics
6%
Pharmacokinetics
6%
Prevalence
6%
Propafenone
13%
Prospective Study
6%
Proton Pump Inhibitor
15%
Recurrence Risk
15%
Recurrent Disease
26%
Renin
20%
Rivaroxaban
20%
Thromboembolism
12%
Warfarin
37%
Medicine and Dentistry
Antiarrhythmic Activity
20%
Apoplexy
6%
Atrial Fibrillation
40%
Cardiac Dysrhythmia
20%
Cardiovascular System
20%
Cardioversion
40%
Mineralocorticoid Antagonist
11%
Persistent Atrial Fibrillation
20%
Recurrence Risk
22%
Recurrent Disease
24%
Renin Angiotensin Aldosterone System
20%
Sinus Rhythm
10%
Transient Ischemic Attack
6%
Biochemistry, Genetics and Molecular Biology
Amiodarone
10%
Blood Plasma
10%
Cardiac Dysrhythmia
10%
Comorbidity
10%
Drug Concentration
10%
Drug Interaction
20%
Dyslipidemia
10%
High Risk Population
10%
Laboratory Test
10%
Pharmacodynamics
10%
Pharmacokinetics
10%
Proton Pump
10%
Quantitative Technique
10%
Rivaroxaban
10%
